Literature DB >> 18555230

Azoospermia after treatment with clomiphene citrate in patients with oligospermia.

Fabio Firmbach Pasqualotto1, Gabriela Poglia Fonseca, Eleonora Bedin Pasqualotto.   

Abstract

OBJECTIVE: To describe three cases of azoospermia in patients with oligospermia after clomiphene citrate (CC) intake.
DESIGN: Case report. SETTING(S): Academic medical center. PATIENT(S): Three patients with oligospermia. INTERVENTION(S): Three oligospermic men used CC, resulting in azoospermia. MAIN OUTCOME MEASURE(S): Semen analysis after CC use and after discontinuation of CC. RESULT(S): Three patients were sent to our clinic for investigation of their azoospermia after use of CC. They had severe oligozoospermia (sperm concentrations of 3.4, 2.8, and 4.1 x 10(6)/mL, respectively) before treatment with CC. These patients were re-evaluated with two new semen analyses, showing azoospermia. After 3 months without use of the drug, the mean sperm concentration was 2.5 +/- 1.1 x 10(6)/mL. CONCLUSION(S): The benefits of empiric treatment with CC must be balanced with the possible undesirable effects, such as azoospermia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555230     DOI: 10.1016/j.fertnstert.2008.03.036

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

Review 1.  Diagnosis and treatment of infertility-related male hormonal dysfunction.

Authors:  Martin Kathrins; Craig Niederberger
Journal:  Nat Rev Urol       Date:  2016-04-19       Impact factor: 14.432

Review 2.  Hormone-Based Treatments in Subfertile Males.

Authors:  Darshan P Patel; Jason C Chandrapal; James M Hotaling
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

Review 3.  Effectiveness of Clomiphene Citrate for Improving Sperm Concentration: A Literature Review and Meta-Analysis.

Authors:  Dragos Puia; Catalin Pricop
Journal:  Cureus       Date:  2022-05-18

Review 4.  Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS).

Authors:  Ankit Desai; Musaab Yassin; Axel Cayetano; Tharu Tharakan; Channa N Jayasena; Suks Minhas
Journal:  Ther Adv Urol       Date:  2022-06-26

5.  Excessive unilateral proliferation of spermatogonia in a patient with non-obstructive azoospermia - adverse effect of clomiphene citrate pre-treatment?

Authors:  Daniela Fietz; Adrian Pilatz; Thorsten Diemer; Florian Wagenlehner; Martin Bergmann; Hans-Christian Schuppe
Journal:  Basic Clin Androl       Date:  2020-09-01

6.  The safety and efficacy of clomiphene citrate in hypoandrogenic and subfertile men.

Authors:  D P Patel; W O Brant; J B Myers; A P Presson; E B Johnstone; J A Dorais; K I Aston; D T Carrell; J M Hotaling
Journal:  Int J Impot Res       Date:  2015-08-20       Impact factor: 2.896

7.  Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men.

Authors:  Sachin V Bendre; Pamela J Murray; Shehzad Basaria
Journal:  Reprod Syst Sex Disord       Date:  2015-11-13

Review 8.  Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use.

Authors:  J Abram McBride; Robert M Coward
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

Review 9.  Frontiers in hormone therapy for male infertility.

Authors:  Iyad Khourdaji; Haerin Lee; Ryan P Smith
Journal:  Transl Androl Urol       Date:  2018-07

10.  The efficacy of anastrozole in subfertile men with and without abnormal testosterone to estradiol ratios.

Authors:  Yang Yang; Shuyun Chen; Hong Chen; Yi Guo; Xiaoming Teng
Journal:  Transl Androl Urol       Date:  2022-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.